The global market (models and services) is valued at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018. Over the years, the use of mice models has increased rapidly. Mice have become the animals of choice for preclinical research in academic institutions as well as in pharmaceutical and biotechnology industries. The market has seen many innovations in the last few years, as companies have introduced new models for studying diseases like cancer and AIDS.
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1308
The biggest factor that is likely to drive the growth of this market is
the ongoing innovations in the development of mice models. In addition, another
factor that is likely to drive the growth of the market is the continuous
research that is undertaken to develop treatments for fatal diseases such as
cancer and HIV/AIDS. Furthermore, research institutes and government bodies
have extended their help in the form of investments, funds, and grants, which
have stimulated research activities to develop mice models. In addition, the
demand for personalized medicines is expected to boost the use of humanized
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1308
North America accounted for the largest share of the protein expression market. On account of the large research budgets and highly evolved pharmaceutical industry in this geographic segment, North America will hold the major share of the global market in the coming years. On the other hand, Asia is expected to grow at a higher CAGR in the forecast period between 2013 and 2018, owing to the increased spending in R&D and large untapped potential of these markets.
The major players in the market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies Corporation (U.S.), Merck Millipore (U.S.), New England BioLabs, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN (Netherlands), Sigma-Aldrich Corporation (U.S.), Takara Bio, Inc. (Japan), and Thermo Fischer Scientific, Inc. (U.S.).
Browse related reports:
Gene Expression Analysis Market by Technology
(DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA
Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis
Software) & Applications] - Global Forecast to 2018
Next Generation Sequencing (NGS) Market
[Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454
Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT),
(Diagnostics, Personalized Medicine)] – Global Forecast to 2017
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets